# Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs

> **NCT03660293** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 150 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Captopril
- **DRUG:** L-carnitine

## Key facts

- **NCT ID:** NCT03660293
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-01
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2019-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03660293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03660293, "Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03660293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*